STAT3 and cancer: EMT is an important process involved in progression of cancers, and previous studies have demonstrated that Stat3 inhibition leads to EMT characterised by up-regulation of epithelial cell-specific proteins (E-cadherin), and by down-regulation of the mesenchymal cell-specific protein N-cadherin33.